Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Sen. Kaler urges state limits on manufacturer restrictions to protect 340B 'original grantees'
Summary
Senator Kaler testified in favor of Senate Bill 198 to bar certain manufacturer restrictions on 340B drug discounts so community health centers and other original covered entities can retain access and reinvest savings in patient care; committee members asked about Planned Parenthood and eligibility issues.
Senator Kaler urged the Senate Health Committee to pass Senate Bill 198 on sponsor testimony, saying the bill would protect the ‘‘original grantees’’ of the federal 340B drug-pricing program and preserve discounted drugs for community health centers and other safety-net providers.
Kaler told the committee that the 340B program, created in 1992, lets eligible safety-net providers — including federally qualified health centers (FQHCs) and HIV/AIDS clinics — purchase outpatient drugs at discounted prices and reinvest savings in patient services such as behavioral health, dental care and transportation. She said the Affordable Care Act’s later expansion of eligibility to more hospitals has ‘‘inflated’’ the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
